Cargando…
Reducing the trigger dose of recombinant hCG in high-responder patients attending an assisted reproductive technology program: an observational study
Decreasing the dose of human chorionic gonadotropin (hCG) used to trigger final oocyte maturation in assisted reproductive technology programs is regarded as a useful intervention in the prevention of ovarian hyperstimulation syndrome, but the minimal effective dose has not been yet identified. In t...
Autores principales: | Tiboni, Gian Mario, Colangelo, Enrica Concetta, Ponzano, Adalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876795/ https://www.ncbi.nlm.nih.gov/pubmed/27274202 http://dx.doi.org/10.2147/DDDT.S105607 |
Ejemplares similares
-
Determinants of the hCG Concentration in the Early Luteal Phase After Final Maturation of Follicles With Bolus Trigger of Recombinant hCG
por: Vuong, Lan N., et al.
Publicado: (2020) -
hCG Triggering in ART: An Evolutionary Concept
por: Hershko Klement, Anat, et al.
Publicado: (2017) -
Biological functions of hCG and hCG-related molecules
por: Cole, Laurence A
Publicado: (2010) -
Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial
por: Decleer, W., et al.
Publicado: (2014) -
GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials
por: Hu, Kai-Lun, et al.
Publicado: (2021)